%0 Journal Article %1 Andrade:2003:Arch-Intern-Med:14504118 %A Andrade, S E %A Majumdar, S R %A Chan, K A %A Buist, D S %A Go, A S %A Goodman, M %A Smith, D H %A Platt, R %A Gurwitz, J H %D 2003 %J Arch Intern Med %K imported %N 17 %P 2052-2057 %R 10.1001/archinte.163.17.2052 %T Low frequency of treatment of osteoporosis among postmenopausal women following a fracture %U http://www.ncbi.nlm.nih.gov/pubmed/14504118?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&linkpos=2&log$=citationsensor %V 163 %X BACKGROUND: Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk of fracture, particularly for postmenopausal women with a history of fracture. METHODS: A retrospective study was conducted using the automated databases of 7 health maintenance organizations to evaluate the use of drugs recommended for secondary prevention of osteoporotic fracture. Women 60 years and older with an inpatient or outpatient diagnostic code for a fracture of the hip, vertebra, or wrist between October 1, 1994, and September 30, 1996, and at least 1 year of continuous enrollment with a drug benefit plan following the date of fracture, were identified. The frequency of use of medications for the treatment of osteoporosis (estrogen replacement therapy, bisphosphonates, and calcitonin) during the 1-year period following the date of the initial fracture was estimated overall and according to patient age, fracture site, and year of fracture. RESULTS: During the study period, 3492 women 60 years and older were diagnosed with a fracture of the hip, vertebra, or wrist, and met the inclusion criteria. Of these patients, 822 (24%) received a drug for osteoporosis treatment during the year following the fracture. The proportion of women receiving treatment for osteoporosis was approximately 2-fold higher among those with a fracture of the vertebra (44%) than among those with a fracture of the hip (21%) or wrist (23%) (P<.001). Of the 2605 women who had not been treated for osteoporosis in the 90 days before a fracture, 14% received treatment for osteoporosis in the year following a fracture. Increasing age was associated with a reduced likelihood of receiving osteoporosis treatment (P<.001). CONCLUSIONS: Most of the older women who had experienced a fracture of the hip, vertebra, or wrist did not receive drug treatment for osteoporosis within 1 year following the fracture. Interventions to improve the detection and treatment of osteoporosis in high-risk patients need to be developed.

@article{Andrade:2003:Arch-Intern-Med:14504118, abstract = {BACKGROUND: Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk of fracture, particularly for postmenopausal women with a history of fracture. METHODS: A retrospective study was conducted using the automated databases of 7 health maintenance organizations to evaluate the use of drugs recommended for secondary prevention of osteoporotic fracture. Women 60 years and older with an inpatient or outpatient diagnostic code for a fracture of the hip, vertebra, or wrist between October 1, 1994, and September 30, 1996, and at least 1 year of continuous enrollment with a drug benefit plan following the date of fracture, were identified. The frequency of use of medications for the treatment of osteoporosis (estrogen replacement therapy, bisphosphonates, and calcitonin) during the 1-year period following the date of the initial fracture was estimated overall and according to patient age, fracture site, and year of fracture. RESULTS: During the study period, 3492 women 60 years and older were diagnosed with a fracture of the hip, vertebra, or wrist, and met the inclusion criteria. Of these patients, 822 (24%) received a drug for osteoporosis treatment during the year following the fracture. The proportion of women receiving treatment for osteoporosis was approximately 2-fold higher among those with a fracture of the vertebra (44%) than among those with a fracture of the hip (21%) or wrist (23%) (P<.001). Of the 2605 women who had not been treated for osteoporosis in the 90 days before a fracture, 14% received treatment for osteoporosis in the year following a fracture. Increasing age was associated with a reduced likelihood of receiving osteoporosis treatment (P<.001). CONCLUSIONS: Most of the older women who had experienced a fracture of the hip, vertebra, or wrist did not receive drug treatment for osteoporosis within 1 year following the fracture. Interventions to improve the detection and treatment of osteoporosis in high-risk patients need to be developed.}, added-at = {2010-03-18T20:22:41.000+0100}, author = {Andrade, S E and Majumdar, S R and Chan, K A and Buist, D S and Go, A S and Goodman, M and Smith, D H and Platt, R and Gurwitz, J H}, biburl = {https://www.bibsonomy.org/bibtex/21b1e624ab6fede7ae0b81e0db7ba29c2/wchun}, description = {Low frequency of treatment of osteoporosis among p... [Arch Intern Med. 2003] - PubMed result}, doi = {10.1001/archinte.163.17.2052}, interhash = {0da4f3306656e87ad8ebe8709dca668e}, intrahash = {1b1e624ab6fede7ae0b81e0db7ba29c2}, journal = {Arch Intern Med}, keywords = {imported}, month = Sep, number = 17, pages = {2052-2057}, pmid = {14504118}, timestamp = {2010-03-18T20:22:41.000+0100}, title = {Low frequency of treatment of osteoporosis among postmenopausal women following a fracture}, url = {http://www.ncbi.nlm.nih.gov/pubmed/14504118?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&linkpos=2&log$=citationsensor}, volume = 163, year = 2003 }